Header Logo

Connection

MENASHE BAR ELI to Clinical Trials, Phase II as Topic

Back to Details
This is a "connection" page, showing publications MENASHE BAR ELI has written about Clinical Trials, Phase II as Topic.
MENASHE BAR ELI
Connection Strength
0.027
Clinical Trials, Phase II as Topic
  1. Integrating Murine and Clinical Trials with Cabozantinib to Understand Roles of MET and VEGFR2 as Targets for Growth Inhibition of Prostate Cancer. Clin Cancer Res. 2016 Jan 01; 22(1):107-21.
    View in: PubMed
    Score: 0.027
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.